Cornelia Schroeder
YOU?
Author Swipe
View article: Data from Improved Risk Stratification by Circulating Tumor Cell Counts in Pancreatic Cancer
Data from Improved Risk Stratification by Circulating Tumor Cell Counts in Pancreatic Cancer Open
Purpose: Pancreatic cancer is one of the most devastating diseases with a 5-year survival rate of 3% to 5%. Here, we investigated whether circulating tumor cells (CTC) may predict metastatic spread and survival in pancreatic cancer patient…
View article: Supplemental Table 1 from Improved Risk Stratification by Circulating Tumor Cell Counts in Pancreatic Cancer
Supplemental Table 1 from Improved Risk Stratification by Circulating Tumor Cell Counts in Pancreatic Cancer Open
Supplements Table 1. Multivariate analyses of progression-free survival and overall survival (n=57) of chemo-receiving patients.
View article: Supplemental Table 1 from Improved Risk Stratification by Circulating Tumor Cell Counts in Pancreatic Cancer
Supplemental Table 1 from Improved Risk Stratification by Circulating Tumor Cell Counts in Pancreatic Cancer Open
Supplements Table 1. Multivariate analyses of progression-free survival and overall survival (n=57) of chemo-receiving patients.
View article: Data from Improved Risk Stratification by Circulating Tumor Cell Counts in Pancreatic Cancer
Data from Improved Risk Stratification by Circulating Tumor Cell Counts in Pancreatic Cancer Open
Purpose: Pancreatic cancer is one of the most devastating diseases with a 5-year survival rate of 3% to 5%. Here, we investigated whether circulating tumor cells (CTC) may predict metastatic spread and survival in pancreatic cancer patient…
View article: PITX1 Is a Regulator of TERT Expression in Prostate Cancer with Prognostic Power
PITX1 Is a Regulator of TERT Expression in Prostate Cancer with Prognostic Power Open
The current risk stratification in prostate cancer (PCa) is frequently insufficient to adequately predict disease development and outcome. One hallmark of cancer is telomere maintenance. For telomere maintenance, PCa cells exclusively empl…
View article: Polygenic and multifactorial scores for pancreatic ductal adenocarcinoma risk prediction
Polygenic and multifactorial scores for pancreatic ductal adenocarcinoma risk prediction Open
Background Most cases of pancreatic ductal adenocarcinoma (PDAC) are asymptomatic in early stages, and the disease is typically diagnosed in advanced phases, resulting in very high mortality. Tools to identify individuals at high risk of d…
View article: Loss of the adhesion molecule CEACAM1 is associated with early biochemical recurrence in <i>TMPRSS2:ERG</i> fusion‐positive prostate cancers
Loss of the adhesion molecule CEACAM1 is associated with early biochemical recurrence in <i>TMPRSS2:ERG</i> fusion‐positive prostate cancers Open
Altered expression of the carcinoembryonic antigen‐related cell adhesion molecule 1 (CEACAM1) has been linked to adverse tumor features in various cancer types. To better understand the role of CEACAM1 in prostate cancer, we analyzed a tis…
View article: Nuclear up regulation of the BRCA1-associated ubiquitinase BAP1 is associated with tumor aggressiveness in prostate cancers lacking the TMPRSS2:ERG fusion
Nuclear up regulation of the BRCA1-associated ubiquitinase BAP1 is associated with tumor aggressiveness in prostate cancers lacking the TMPRSS2:ERG fusion Open
Loss of the putative tumor suppressor BAP1 is a candidate biomarker for adverse prognosis in many cancer types, but conversely for improved survival in others. Studies on the expression and prognostic role of BAP1 in prostate cancer are cu…
View article: Expression of CCCTC‐binding factor (CTCF) is linked to poor prognosis in prostate cancer
Expression of CCCTC‐binding factor (CTCF) is linked to poor prognosis in prostate cancer Open
The chromatin‐organizing factor CCCTC‐binding factor (CTCF) is involved in transcriptional regulation, DNA‐loop formation, and telomere maintenance. To evaluate the clinical impact of CTCF in prostate cancer, we analyzed CTCF expression by…
View article: High RSF1 protein expression is an independent prognostic feature in prostate cancer
High RSF1 protein expression is an independent prognostic feature in prostate cancer Open
Background: Remodelling and spacing factor 1 (RSF1) is involved in the regulation of chromatin remodelling and represents a potential therapeutic target. High RSF1 expression has been linked to adverse tumour features in many cancer types,…
View article: Nuclear ELAC2 overexpression is associated with increased hazard for relapse after radical prostatectomy
Nuclear ELAC2 overexpression is associated with increased hazard for relapse after radical prostatectomy Open
ELAC2 is a ubiquitously expressed enzyme potentially involved in tRNA processing and cell signaling pathways. Mutations of the ELAC2 gene have been found to confer increased prostate cancer susceptibility in families. ELAC2 protein express…
View article: Aberrant expression of the microtubule-associated protein tau is an independent prognostic feature in prostate cancer
Aberrant expression of the microtubule-associated protein tau is an independent prognostic feature in prostate cancer Open
The results of our study identify MAPT, as a moderate prognostic marker in prostate cancer, whose clinical impact, however, may be limited due to the rarity and heterogeneity of its expression.
View article: Issue Information
Issue Information Open
Where the subscription price includes print issues and delivery is to the recipient's address, delivery terms are Delivered at Place (DAP); the recipient is responsible for paying any import duty or taxes.Title to all issues transfers FOB …
View article: Upregulation of centromere protein F is linked to aggressive prostate cancers
Upregulation of centromere protein F is linked to aggressive prostate cancers Open
The results of our study identify CENPF overexpression as an important mechanism and a potential biomarker for prostate cancer aggressiveness.
View article: High expression of class III β‑tubulin in upper gastrointestinal cancer types
High expression of class III β‑tubulin in upper gastrointestinal cancer types Open
Class III β-tubulin (TUBB3) is a component of microtubules of neuronal cells that is upregulated in various cancer entities. To better understand the role of TUBB3 in upper gastrointestinal tract cancer types, the present study assessed TU…
View article: Lipidomimetic Compounds Act as HIV-1 Entry Inhibitors by Altering Viral Membrane Structure
Lipidomimetic Compounds Act as HIV-1 Entry Inhibitors by Altering Viral Membrane Structure Open
The envelope of Human Immunodeficiency Virus type 1 (HIV-1) consists of a liquid-ordered membrane enriched in raft lipids and containing the viral glycoproteins. Previous studies demonstrated that changes in viral membrane lipid compositio…
View article: FOXA1 expression is a strong independent predictor of early PSA recurrence in ERG negative prostate cancers treated by radical prostatectomy
FOXA1 expression is a strong independent predictor of early PSA recurrence in ERG negative prostate cancers treated by radical prostatectomy Open
FOXA1 (Fork-head box protein A1, HNF-3a) is a transcription factor involved in androgen signaling with relevance for lineage-specific gene expression of the prostate. The expression was analyzed by immunohistochemistry on a tissue microarr…
View article: High-Level γ-Glutamyl-Hydrolase (GGH) Expression is Linked to Poor Prognosis in ERG Negative Prostate Cancer
High-Level γ-Glutamyl-Hydrolase (GGH) Expression is Linked to Poor Prognosis in ERG Negative Prostate Cancer Open
γ-glutamyl-hydrolase (GGH) is a ubiquitously-expressed enzyme that regulates intracellular folate metabolism for cell proliferation, DNA synthesis, and repair. Employing GGH immunohistochemistry on a tissue microarray with 12,427 prostate …